The Natural Products Association has attempted to get out ahead of a potential issue for the industry by asking federal authorities to monitor dietary supplement companies claiming to treat coronavirus infections.
Over 99.7% of the infant formula sold in China have passed sampling inspection as of December last year. But surprisingly, some of those made in Australia and New Zealand were among those which failed to meet the cut.
Three years after Singapore officially launched its War on Diabetes campaign, with the aim of ‘mobilising the whole nation’ to tackle the condition, we assess how the food and beverage industry has been a key ally in the battle.
In this round up, we look at some of the new developments that took place in APAC’s health and nutrition regulatory space, including the South Korean authorities’ clampdown on influencers ads that made false health claims.
APAC’s fragmented, and at times volatile, regulatory landscape can be a major headache for supplements and functional foods firms. As we enter 2020, we look at some of the new rules that will commence from January and the developments that are likely...
See the regulatory developments happening in APAC in the past one month, including Taiwan FDA's new rules for vitamins labelling, Australia drafting regulations to govern the manufacturing process and uses of faecal microbiota transplant (FMT) products....
More than 40% of dietary supplements may not be as effective as touted to be, after 100 products tested by Japan’s National Consumer Affairs Center (NCAC) were unable to dissolve in water within the specified time limits.
Our 10 most read regulatory stories concerning APAC's health foods and supplement industry include India permits marijuana cultivation for research and medicine, China’s proposal for stricter infant-formula manufacturing processes and more.